Acellular Pertussis Completed Phase 4 Trials for Trazodone (DB00656)

IndicationStatusPhase
DBCOND0031302 (Acellular Pertussis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00282295US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal DiseasePrevention